Ibnsina Pharma

CASE:ISPH Stock Report

Market Cap: ج.م5.5b

Ibnsina Pharma Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Mohamed Mohsen Mahgoub

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure3.6yrs
CEO ownershipn/a
Management average tenureno data
Board average tenure7.1yrs

Recent management updates

Recent updates

CEO

Mohamed Mohsen Mahgoub

3.6yrs

Tenure

Mr. Mohamed Mohsen Mohamed Mahgoub serves as Vice Chairman and Chief Executive Officer at Ibn Sina Pharma (S.A.E) since April 2021. He served as Executive Chairman until April 2021 and has been Director at...

Board Members

NamePositionTenureCompensationOwnership
Mohamed Mohsen Mahgoub
Vice Chairman & CEO7.1yrsno datano data
Mahmoud Abdel-Gawad
Co-CEO & Director7.1yrsno data4.91%
EGP 269.9m
Omar Abdel-Gawad
Co-CEO & Director7.1yrsno data5.91%
EGP 324.4m
Mohamed Mohsen Mahgoub
Director7.1yrsno data8.12%
EGP 446.0m
Hany Hassanein Bader
Director7.1yrsno datano data
Abdel Fahmy
Director7.1yrsno datano data
Mohamed Abbas Mohamed Zaki
Director7.1yrsno data2.31%
EGP 127.1m
Abdel Aziz Abdel Aziz
Non-Executive Chairman7.1yrsno data0.15%
EGP 8.3m
Ahmed Abdelgawad Mahmoud
Directorno datano data4.61%
EGP 253.2m
Ahmed Al Nawawi
Directorno datano datano data

7.1yrs

Average Tenure

Experienced Board: ISPH's board of directors are considered experienced (7.1 years average tenure).